Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr;83(4):1-6.
doi: 10.1055/s-0045-1805073. Epub 2025 Mar 19.

Immune-mediated insights into clinical and specific autoantibodies in acute and chronic immune-mediated nodo-paranodopathies

Affiliations
Review

Immune-mediated insights into clinical and specific autoantibodies in acute and chronic immune-mediated nodo-paranodopathies

Marcus Vinícius Magno Gonçalves et al. Arq Neuropsiquiatr. 2025 Apr.

Abstract

The recognition of the molecular structures, namely the node of Ranvier and the axonal regions surrounding it (the paranode and juxtaparanode), as the primary target for specific autoantibodies has introduced a new site for neurological location (microtopographic structures), in contrast to the prevailing understanding, in which lesions to neural macrostructures (roots, nerves, and/or plexus) were the focus of semiologists and electrophysiologists for topographic, syndromic, and nosological diagnoses. Therefore, there was a need to understand and characterize the components of these neural microstructures that are grouped in small regions within the nerve to optimize clinical and therapeutic reasoning.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

Figure 1
Figure 1
Nodal, paranodal, and juxtaparanodal regions with their main antigens, the presence of sodium channels in the nodal region, and of potassium channels in the juxtaparanodal regions. Predominance of immunoglobulin G1 (IgG1) to IG3 and IgM antibodies in the nodal region, and of IgG4 and 3 antibodies in the paranodal and juxtaparanodal regions.

References

    1. Van den Bergh P YK, van Doorn P A. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. J Peripher Nerv Syst. 2021;26(03):242–268. doi: 10.1111/jns.12455. - DOI - PubMed
    1. Bunschoten C, Jacobs B C, Van den Bergh P YK, Cornblath D R, van Doorn P A. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Lancet Neurol. 2019;18(08):784–794. doi: 10.1016/S1474-4422(19)30144-9. - DOI - PubMed
    1. Koike H, Kadoya M, Kaida K I et al. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies. J Neurol Neurosurg Psychiatry. 2017;88(06):465–473. doi: 10.1136/jnnp-2016-314895. - DOI - PubMed
    1. Schafer D P, Bansal R, Hedstrom K L, Pfeiffer S E, Rasband M N. Does paranode formation and maintenance require partitioning of neurofascin 155 into lipid rafts? J Neurosci. 2004;24(13):3176–3185. doi: 10.1523/JNEUROSCI.5427-03.2004. - DOI - PMC - PubMed
    1. Uncini A, Vallat J M. Autoimmune nodo-paranodopathies of peripheral nerve: the concept is gaining ground. J Neurol Neurosurg Psychiatry. 2018;89(06):627–635. doi: 10.1136/jnnp-2017-317192. - DOI - PubMed

MeSH terms

LinkOut - more resources